Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)
- 1 August 1986
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 69 (2), 192-197
- https://doi.org/10.1016/0304-3940(86)90602-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- MPTP-Induced Parkinsonian Syndromes in Humans and AnimalsPublished by Springer Nature ,1986
- β-Carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?Neuroscience Letters, 1985
- Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the MouseJournal of Neurochemistry, 1985
- Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTPEuropean Journal of Pharmacology, 1984
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- Manganese neurotoxicity: a model for free radical mediated neurodegeneration?Canadian Journal of Physiology and Pharmacology, 1982
- A mechanism of paraquat toxicity in mice and ratsToxicology and Applied Pharmacology, 1976